Menopausal hormone therapy prior to the diagnosis of ovarian cancer is associated with improved survival
Katharine K. Brieger(University of Michigan), Malcolm C. Pike(Kettering University), Allan Jensen(Danish Cancer Society), Karen McLean(University of Michigan), Ellen L. Goode(Mayo Clinic in Arizona), Hui Shen(Van Andel Institute), Penelope M. Webb(QIMR Berghofer Medical Research Institute), Sharon E. Johnatty(QIMR Berghofer Medical Research Institute), Anna DeFazio(The University of Sydney), David D.L. Bowtell(The University of Melbourne), Michael S. Anglesio(University of British Columbia), Gillian E. Hanley(University of British Columbia), Estrid Høgdall(University of Copenhagen), Kathleen R. Cho(University of Michigan), Susanne K. Kjær(Copenhagen University Hospital), Marc T. Goodman(Cedars-Sinai Medical Center), Andrew Berchuck(General Marble (Greece)), Siri Peterson(University of Michigan), Georgia Chenevix‐Trench(QIMR Berghofer Medical Research Institute), Simon A. Gayther(The University of Texas Health Science Center at Houston), Jean L. Richardson(University of Southern California), Britton Trabert(St. Elizabeth's Hospital), Aleksandra Gentry‐Maharaj(UCL Australia), Susan J. Ramus(Cancer Institute of New South Wales), Kathryn L. Terry(Brigham and Women's Hospital), Kirsten B. Moysich(American Cancer Society), Renée T. Fortner(Norwegian Institute of Public Health), Daniel W. Cramer(Brigham and Women's Hospital), Nicolas Wentzensen(National Cancer Institute), Holly R. Harris(Fred Hutch Cancer Center), Kelly M. Bakulski(University of Michigan), Argyrios Ziogas(University of Copenhagen), Anna H. Wu(University of Southern California), Jennifer A. Doherty(Cancer Prevention Institute of California), Jolanta Kupryjańczyk(Cedars-Sinai Medical Center), Francesmary Modugno(University of Pittsburgh), Susan J. Jordan(The University of Queensland), Aliya Alimujiang(University of Michigan), Hoda Anton‐Culver(University of California, Irvine), Dale W. Garsed(Peter MacCallum Cancer Centre), Diether Lambrechts(VIB-KU Leuven Center for Cancer Biology), Usha Menon(University of South Florida), Bhramar Mukherjee(Michigan Medicine), David G. Huntsman(BC Cancer Agency), Paul D.P. Pharoah(Cedars-Sinai Medical Center), Alice W. Lee(California State University, Fullerton), Mary Anne Rossing(Fred Hutch Cancer Center), Harvey A. Risch(University of New Haven), Roberta B. Ness(The University of Texas Health Science Center at Houston), Elisa V. Bandera(Rutgers, The State University of New Jersey)
Cited by 29
Related Papers
Mutations of the BRAF gene in human cancer
|Nature|2002|10.7k
Integrated genomic analyses of ovarian carcinoma
|Nature|2011|8.2k
Comprehensive molecular characterization of gastric adenocarcinoma
|Nature|2014|6.6k
The Immune Landscape of Cancer
|Immunity|2018|6.3k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k